Blog

“If someone has done it before, I can do it too – if no one has done it, I can be the first”: for 30 years, this compass has guided the prolific scientific career of Dr. Pablo Escribá, founder and CEO of Laminar Pharma....

If there is something that is set in stone in the biopharma sector, it is the fact that bringing an innovative molecule with therapeutic potential to the market is a long-distance race. If this is true even for companies already settled in the market, recently...

Many drugs that are available in the market have something in common, regarding how they make effect: they directly target one or more proteins. And this is not a coincidence. Proteins perform a vast range of functions within the cells of all living organisms that...